Pages that link to "Q35709083"

The following pages link to Digoxin inhibits development of hypoxic pulmonary hypertension in mice (Q35709083):

Displaying 42 items.

• "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols (Q26741122) (← links)
• A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? (Q27026643) (← links)
• Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cells (Q28397747) (← links)
• Effects of 17β-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats (Q33723858) (← links)
• Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension (Q33920050) (← links)
• The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes (Q35115789) (← links)
• Na(+)/H(+) exchange and hypoxic pulmonary hypertension (Q35665720) (← links)
• Upregulation of canonical transient receptor potential channel in the pulmonary arterial smooth muscle of a chronic thromboembolic pulmonary hypertension rat model. (Q35686329) (← links)
• Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling (Q35887239) (← links)
• Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury (Q36041722) (← links)
• Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning (Q36068993) (← links)
• Hypoxia-induced migration in pulmonary arterial smooth muscle cells requires calcium-dependent upregulation of aquaporin 1 (Q36178060) (← links)
• Vascular remodeling in pulmonary hypertension (Q36644607) (← links)
• Low ambient oxygen prevents atherosclerosis (Q36717280) (← links)
• Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. (Q36764714) (← links)
• Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development (Q36810837) (← links)
• Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension (Q36902375) (← links)
• Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2. (Q37054481) (← links)
• Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases (Q37057231) (← links)
• Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. (Q37487004) (← links)
• Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series). (Q37555431) (← links)
• miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation (Q37556377) (← links)
• HIF and pulmonary vascular responses to hypoxia (Q37679350) (← links)
• Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. (Q37688525) (← links)
• Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology (Q38128383) (← links)
• Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension (Q38558147) (← links)
• Lung Circulation (Q38804579) (← links)
• Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration (Q39710763) (← links)
• Protective effects of heat shock protein 70 against hypoxic pulmonary hypertension in neonatal rats (Q40374764) (← links)
• "A small leak will sink a great ship": hypoxia-inducible factor and group III pulmonary hypertension (Q42413284) (← links)
• 55th Bowditch Lecture: Effects of chronic hypoxia on the pulmonary circulation: role of HIF-1. (Q42415178) (← links)
• A Brief Overview of Nitric Oxide and Reactive Oxygen Species Signaling in Hypoxia-Induced Pulmonary Hypertension (Q46280881) (← links)
• Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease (Q47292596) (← links)
• Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension (Q47602826) (← links)
• Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition". (Q49203906) (← links)
• Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor (Q89167704) (← links)
• Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension (Q89344744) (← links)
• Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia (Q90625006) (← links)
• Pharmacologic Targeting of Hypoxia-Inducible Factors (Q90963815) (← links)
• Digoxin Attenuates Receptor Activation of NF-κB Ligand-Induced Osteoclastogenesis in Macrophages (Q91997820) (← links)
• Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension (Q92984589) (← links)
• Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway (Q94560908) (← links)